PressReleases Investors Home Press Releases Events & Presentations Financials & Filings Stock Information Governance Year All2024202320222021202020192018 May 14, 2024 Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update May 03, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 24, 2024 Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Apr 09, 2024 Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting Apr 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 26, 2024 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update Mar 05, 2024 Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting Mar 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 27, 2024 Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference Feb 05, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Print page >> Contact us >> RSS >> Email alerts >>
Year All2024202320222021202020192018 May 14, 2024 Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update May 03, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apr 24, 2024 Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Apr 09, 2024 Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting Apr 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 26, 2024 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update Mar 05, 2024 Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting Mar 04, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Feb 27, 2024 Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference Feb 05, 2024 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 14, 2024 Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
Apr 24, 2024 Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 09, 2024 Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
Mar 26, 2024 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
Mar 05, 2024 Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
